SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Passage BIO, Inc. – ‘10-Q’ for 6/30/22 – ‘EXCEL’

On:  Thursday, 8/4/22, at 7:15am ET   ·   For:  6/30/22   ·   Accession #:  1558370-22-12042   ·   File #:  1-39231

Previous ‘10-Q’:  ‘10-Q’ on 5/16/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/10/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 5/14/24 for 3/31/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/22  Passage BIO, Inc.                 10-Q        6/30/22   58:6.6M                                   Toppan Merrill Bridge/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.13M 
 2: EX-10.1     Material Contract                                   HTML     66K 
 3: EX-10.2     Material Contract                                   HTML     36K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
13: R1          Document and Entity Information                     HTML     73K 
14: R2          Balance Sheets                                      HTML    107K 
15: R3          Balance Sheets (Parenthetical)                      HTML     25K 
16: R4          Statements of Operations and Comprehensive Loss     HTML     71K 
17: R5          Statements of Stockholders' Equity                  HTML     84K 
18: R6          Statements of Stockholders' Equity (Parenthetical)  HTML     18K 
19: R7          Statements of Cash Flows                            HTML    103K 
20: R8          Nature of Operations                                HTML     21K 
21: R9          Risks and Liquidity                                 HTML     22K 
22: R10         Summary of Significant Accounting Policies          HTML     40K 
23: R11         Cash, cash equivalents and marketable securities    HTML    111K 
24: R12         Fair Value of Financial Instruments                 HTML    112K 
25: R13         Property and Equipment, net                         HTML     36K 
26: R14         Accrued Expenses and Other Current Liabilities      HTML     32K 
27: R15         Leases                                              HTML     54K 
28: R16         Commitments and Contingencies                       HTML     32K 
29: R17         Share-Based Compensation                            HTML     99K 
30: R18         Subsequent Events                                   HTML     20K 
31: R19         Summary of Significant Accounting Policies          HTML     61K 
                (Policies)                                                       
32: R20         Summary of Significant Accounting Policies          HTML     28K 
                (Tables)                                                         
33: R21         Cash, cash equivalents and marketable securities    HTML    112K 
                (Tables)                                                         
34: R22         Fair Value of Financial Instruments (Tables)        HTML    108K 
35: R23         Property and Equipment, net (Tables)                HTML     34K 
36: R24         Accrued Expenses and Other Current Liabilities      HTML     32K 
                (Tables)                                                         
37: R25         Leases (Tables)                                     HTML     49K 
38: R26         Share-Based Compensation (Tables)                   HTML     96K 
39: R27         Risks and Liquidity (Details)                       HTML     30K 
40: R28         Summary of Significant Accounting Policies          HTML     35K 
                (Details)                                                        
41: R29         Cash, cash equivalents and marketable securities -  HTML     31K 
                Portfolio of Cash and Cash Equivalents (Details)                 
42: R30         Cash, cash equivalents and marketable securities -  HTML     43K 
                Portfolio of Marketable Securities (Details)                     
43: R31         Fair Value of Financial Instruments (Details)       HTML     55K 
44: R32         Property and Equipment, net (Details)               HTML     39K 
45: R33         Accrued Expenses and Other Current Liabilities      HTML     30K 
                (Details)                                                        
46: R34         Leases (Details)                                    HTML     80K 
47: R35         Leases - Operating lease cost (Details)             HTML     26K 
48: R36         Commitments and Contingencies - Collaboration       HTML     65K 
                Agreements (Details)                                             
49: R37         Share-Based Compensation - Equity Incentive Plan &  HTML     62K 
                ESPP (Details)                                                   
50: R38         Share-Based Compensation - Share-based              HTML     28K 
                compensation expense (Details)                                   
51: R39         Share-Based Compensation - Stock Option Activity    HTML     67K 
                (Details)                                                        
52: R40         Share-Based Compensation - Assumptions Used in      HTML     25K 
                Determining Fair Value & Early exercise of Stock                 
                Options (Details)                                                
53: R41         Share-Based Compensation - Restricted Stock Units   HTML     46K 
                (Details)                                                        
56: XML         IDEA XML File -- Filing Summary                      XML     97K 
54: XML         XBRL Instance -- pasg-20220630x10q_htm               XML   1.41M 
55: EXCEL       IDEA Workbook of Financial Reports                  XLSX     68K 
 9: EX-101.CAL  XBRL Calculations -- pasg-20220630_cal               XML    116K 
10: EX-101.DEF  XBRL Definitions -- pasg-20220630_def                XML    316K 
11: EX-101.LAB  XBRL Labels -- pasg-20220630_lab                     XML    905K 
12: EX-101.PRE  XBRL Presentations -- pasg-20220630_pre              XML    597K 
 8: EX-101.SCH  XBRL Schema -- pasg-20220630                         XSD    121K 
57: JSON        XBRL Instance as JSON Data -- MetaLinks              270±   391K 
58: ZIP         XBRL Zipped Folder -- 0001558370-22-012042-xbrl      Zip    336K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/24  Passage BIO, Inc.                 10-K       12/31/23   73:10M                                    Toppan Merrill Bridge/FA
 3/06/23  Passage BIO, Inc.                 10-K       12/31/22   70:9M                                     Toppan Merrill Bridge/FA
Top
Filing Submission 0001558370-22-012042   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 11:38:36.1pm ET